InfuSystem Holdings (INFU) Amortizatization of Intangibles (2010 - 2026)
InfuSystem Holdings (INFU) reported Amortizatization of Intangibles of $209000.0 for Q1 2026, down 15.73% on a YoY basis from $248000.0 in Q1 2025, and up 4.5% quarter-over-quarter from $200000.0 in Q4 2025.
InfuSystem Holdings (INFU) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Amortizatization of Intangibles for 11 years, with the latest figure at $209000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 15.73% year-over-year to $209000.0; the trailing twelve-month figure through Mar 2026 stood at $870000.0 (down 8.61% YoY), and the FY2025 full-year result was $900000.0, down 10.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $209000.0, up from $200000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $711000.0 in Q2 2022, with the low at $200000.0 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $320117.6 across 5 years, with a median of $247000.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles tumbled 71.87% — and 2025, when it gained 24.0%.
- InfuSystem Holdings' Amortizatization of Intangibles stood at $400000.0 in 2022, then plunged by 35.75% to $257000.0 in 2023, then changed by 0.0% to $257000.0 in 2024, then retreated by 22.18% to $200000.0 in 2025, then advanced by 4.5% to $209000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $209000.0 (Q1 2026), $200000.0 (Q4 2025), and $214000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 6.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 75.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 209,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,000.00 |
| Mar 31, 2026 | 209,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 214,000.00 |
| Sep 30, 2025 | 214,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 247,000.00 |
| Jun 30, 2024 | 247,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 257,000.00 |
| Dec 31, 2023 | 257,000.00 |